Neogen (NEOG) Income from Non-Controlling Interests (2011 - 2018)
Neogen's (NEOG) quarterly Income from Non-Controlling Interests came in at -$5000.0 in Q1 2018, down 105.56% year-on-year from $90000.0 in Q1 2017, and down 109.43% quarter-over-quarter from $53000.0 in Q4 2017.
Neogen (NEOG) Income from Non-Controlling Interests (2011 - 2018) Analysis & Trends
Neogen's Income from Non-Controlling Interests history runs 8 years deep, the most recent figure standing at -$5000.0 for Q1 2018.
- On a quarterly basis, Income from Non-Controlling Interests fell 105.56% year-over-year to -$5000.0 in Q1 2018; TTM through May 2019 was -$5000.0, a 107.14% decrease from a year earlier, with the FY2018 full-year figure at $70000.0, down 61.11% from the prior year.
- Income from Non-Controlling Interests fell to -$5000.0 in Q1 2018 per NEOG's latest filing, from $53000.0 in the prior quarter.
- Across five years, Income from Non-Controlling Interests topped out at $90000.0 in Q1 2017 and bottomed at -$45000.0 in Q1 2015.
- The 5-year median for Income from Non-Controlling Interests is $20000.0 (2014), against an average of $15823.5.
- Across the five-year window, Income from Non-Controlling Interests slumped 230.77% in 2015 and surged 509.09% in 2017, its largest moves.
- Year by year, Income from Non-Controlling Interests stood at $20000.0 in 2014, then jumped by 245.0% to $69000.0 in 2015, then sank by 71.01% to $20000.0 in 2016, then soared by 165.0% to $53000.0 in 2017, then sank by 109.43% to -$5000.0 in 2018.
- Per Business Quant, the three latest NEOG Income from Non-Controlling Interests figures stand at -$5000.0 (Q1 2018), $53000.0 (Q4 2017), and $22000.0 (Q3 2017).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 16.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 22.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -5.85 Mn |
| 10 | Neogen | 2.03 Bn | 1.87 Bn | 99.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2018 | -5,000.00 |
| Nov 30, 2017 | 53,000.00 |
| Aug 31, 2017 | 22,000.00 |
| May 31, 2017 | 17,000.00 |
| Feb 28, 2017 | 90,000.00 |
| Nov 30, 2016 | 20,000.00 |
| Aug 31, 2016 | 53,000.00 |
| May 31, 2016 | -38,000.00 |
| Feb 29, 2016 | -22,000.00 |
| Nov 30, 2015 | 69,000.00 |
| Aug 31, 2015 | -34,000.00 |
| May 31, 2015 | 49,000.00 |
| Feb 28, 2015 | -45,000.00 |
| Nov 30, 2014 | 20,000.00 |
| Aug 31, 2014 | 26,000.00 |
| May 31, 2014 | 16,000.00 |
| Feb 28, 2014 | -22,000.00 |
| Nov 30, 2013 | 21,000.00 |
| Aug 31, 2013 | -142,000.00 |
| May 31, 2013 | -55,000.00 |